Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination

A. Suchankova, L. Ritterova, M. Krcmar, V. Krchnak, Josef Vagner, I. L. Jochmus Gissmann, J. Kanka, V. Vonka

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2%) than in the other individuals (six of 106, 5.7%). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.

Original languageEnglish (US)
Pages (from-to)2577-2581
Number of pages5
JournalJournal of General Virology
Volume72
Issue number10
StatePublished - 1991
Externally publishedYes

Fingerprint

Human papillomavirus 16
Western Blotting
Enzyme-Linked Immunosorbent Assay
Antibodies
Serum
Epitopes
Peptides
Proteins
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Immunoglobulin G
Carcinoma
Amino Acids

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Suchankova, A., Ritterova, L., Krcmar, M., Krchnak, V., Vagner, J., Jochmus Gissmann, I. L., ... Vonka, V. (1991). Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. Journal of General Virology, 72(10), 2577-2581.

Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. / Suchankova, A.; Ritterova, L.; Krcmar, M.; Krchnak, V.; Vagner, Josef; Jochmus Gissmann, I. L.; Kanka, J.; Vonka, V.

In: Journal of General Virology, Vol. 72, No. 10, 1991, p. 2577-2581.

Research output: Contribution to journalArticle

Suchankova, A, Ritterova, L, Krcmar, M, Krchnak, V, Vagner, J, Jochmus Gissmann, IL, Kanka, J & Vonka, V 1991, 'Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination', Journal of General Virology, vol. 72, no. 10, pp. 2577-2581.
Suchankova A, Ritterova L, Krcmar M, Krchnak V, Vagner J, Jochmus Gissmann IL et al. Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. Journal of General Virology. 1991;72(10):2577-2581.
Suchankova, A. ; Ritterova, L. ; Krcmar, M. ; Krchnak, V. ; Vagner, Josef ; Jochmus Gissmann, I. L. ; Kanka, J. ; Vonka, V. / Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. In: Journal of General Virology. 1991 ; Vol. 72, No. 10. pp. 2577-2581.
@article{5fd835520339423db7fd98dc1d90c274,
title = "Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination",
abstract = "A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2{\%}) than in the other individuals (six of 106, 5.7{\%}). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.",
author = "A. Suchankova and L. Ritterova and M. Krcmar and V. Krchnak and Josef Vagner and {Jochmus Gissmann}, {I. L.} and J. Kanka and V. Vonka",
year = "1991",
language = "English (US)",
volume = "72",
pages = "2577--2581",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",
number = "10",

}

TY - JOUR

T1 - Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination

AU - Suchankova, A.

AU - Ritterova, L.

AU - Krcmar, M.

AU - Krchnak, V.

AU - Vagner, Josef

AU - Jochmus Gissmann, I. L.

AU - Kanka, J.

AU - Vonka, V.

PY - 1991

Y1 - 1991

N2 - A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2%) than in the other individuals (six of 106, 5.7%). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.

AB - A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2%) than in the other individuals (six of 106, 5.7%). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.

UR - http://www.scopus.com/inward/record.url?scp=0025952542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025952542&partnerID=8YFLogxK

M3 - Article

C2 - 1655964

AN - SCOPUS:0025952542

VL - 72

SP - 2577

EP - 2581

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

IS - 10

ER -